Journey Medical Corporation DERM Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Journey Medical Corporation's operating cash flow?
- Journey Medical Corporation (DERM) reported operating cash flow of $2.91M in Q1 2026.
- How has Journey Medical Corporation's operating cash flow changed year-over-year?
- Journey Medical Corporation's operating cash flow increased by 202.7% year-over-year, from -$2.83M to $2.91M.
- What is the long-term trend for Journey Medical Corporation's operating cash flow?
- Over 2 years (2021 to 2025), Journey Medical Corporation's operating cash flow has grown at a 138.8% compound annual growth rate (CAGR), from -$2.18M to -$12.44M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.